Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

3rd Dry AMD Therapeutics Summit

Evvnt Promotion / evvnt
-
30.11.2022 - 02.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 07:50 - 12:00
 
Temi della conferenza
2022 hosts the race between IVERIC Bio and Apellis for regulatory approval of the very first marketable dry AMD treatment. In addition to clinical advances, the field will see plenty of technology advances for more patient-compliant therapeutics, with the favourable one-dose gene therapy approach addition to pipelines, and optimized biomarker technology.

Join our 30+ expert speakers as we tackle the most critical roadblocks preventing your drugs getting the patients who need them.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1279770-3?pid=4832

Speakers: Abraham Scaria | Chief Scientific Officer | AGTC, Anneke Der Hollander | Senior Principal Scientist and Ophthalmology Lead | AbbVie, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1279770-2?pid=4832
Ms. Stephanie Nketia
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 3997.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Health Forum GasteinEuropean Public Health Association (EUPHA)Ärzte der WeltHilfswerk AustriaAMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.Alumni Club Medizinische Universität WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario